Clonal Genetic Evolution at Relapse of Favorable-risk Acute Myeloid Leukemia with Mutation is Associated with Phenotypic Changes and Worse Outcomes

Ferrell Jr P, Diggins K, Polikowsky H, Mohan S, Seegmiller A, Irish J . High-Dimensional Analysis of Acute Myeloid Leukemia Reveals Phenotypic Changes in Persistent Cells during Induction Therapy. PLoS One. 2016; 11(4):e0153207. PMC: 4830605. DOI: 10.1371/journal.pone.0153207. View

Kronke J, Bullinger L, Teleanu V, Tschurtz F, Gaidzik V, Kuhn M . Clonal evolution in relapsed NPM1-mutated acute myeloid leukemia. Blood. 2013; 122(1):100-8. DOI: 10.1182/blood-2013-01-479188. View

Ho T, LaMere M, Stevens B, Ashton J, Myers J, ODwyer K . Evolution of acute myelogenous leukemia stem cell properties after treatment and progression. Blood. 2016; 128(13):1671-8. PMC: 5043124. DOI: 10.1182/blood-2016-02-695312. View

Hourigan C, Gale R, Gormley N, Ossenkoppele G, Walter R . Measurable residual disease testing in acute myeloid leukaemia. Leukemia. 2017; 31(7):1482-1490. DOI: 10.1038/leu.2017.113. View

Sood R, Hansen N, Donovan F, Carrington B, Bucci D, Maskeri B . Somatic mutational landscape of AML with inv(16) or t(8;21) identifies patterns of clonal evolution in relapse leukemia. Leukemia. 2015; 30(2):501-4. PMC: 4679720. DOI: 10.1038/leu.2015.141. View

Heath E, Chan S, Minden M, Murphy T, Shlush L, Schimmer A . Biological and clinical consequences of NPM1 mutations in AML. Leukemia. 2017; 31(4):798-807. DOI: 10.1038/leu.2017.30. View

Ding L, Ley T, Larson D, Miller C, Koboldt D, Welch J . Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature. 2012; 481(7382):506-10. PMC: 3267864. DOI: 10.1038/nature10738. View

Yebenes-Ramirez M, Serrano J, Martinez-Losada C, Sanchez-Garcia J . [Clinical and biological prognostic factors in relapsed acute myeloid leukemia patients]. Med Clin (Barc). 2016; 147(5):185-191. DOI: 10.1016/j.medcli.2016.05.015. View

Thomas D, Majeti R . Biology and relevance of human acute myeloid leukemia stem cells. Blood. 2017; 129(12):1577-1585. PMC: 5364335. DOI: 10.1182/blood-2016-10-696054. View

10.

Getta B, Devlin S, Levine R, Arcila M, Mohanty A, Zehir A . Multicolor Flow Cytometry and Multigene Next-Generation Sequencing Are Complementary and Highly Predictive for Relapse in Acute Myeloid Leukemia after Allogeneic Transplantation. Biol Blood Marrow Transplant. 2017; 23(7):1064-1071. PMC: 9810388. DOI: 10.1016/j.bbmt.2017.03.017. View

11.

Cui W, Zhang D, Cunningham M, Tilzer L . Leukemia-associated aberrant immunophenotype in patients with acute myeloid leukemia: changes at refractory disease or first relapse and clinicopathological findings. Int J Lab Hematol. 2014; 36(6):636-49. DOI: 10.1111/ijlh.12193. View

12.

Parkin B, Ouillette P, Li Y, Keller J, Lam C, Roulston D . Clonal evolution and devolution after chemotherapy in adult acute myelogenous leukemia. Blood. 2012; 121(2):369-77. PMC: 3653567. DOI: 10.1182/blood-2012-04-427039. View

13.

Dohner H, Estey E, Grimwade D, Amadori S, Appelbaum F, Buchner T . Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2016; 129(4):424-447. PMC: 5291965. DOI: 10.1182/blood-2016-08-733196. View